Roche - Genentech takeover timeline

/ 1995 Views

Genentech to Roche: We’re equipped for hard times

04/03/2009

Genentech believes a far-sighted approach to patent expiration, unique and life saving drugs and an unrivalled scientific culture will protect it from recession and ensure greater growth than Roche...

"Anywhere, anytime" – Genentech challenges Roche

03/03/2009

Genentech used its investor meeting to retaliate against criticisms made by Roche, saying it will debate its financial model “anywhere, anytime with anyone”.

Genentech warns board could turn hostile

23/02/2009

As the battle for Genentech continues, the US biotech has warned its shareholders that Roche may “seek to influence our business in a manner that is contrary to our goals or strategies”.

Roche “not prepared to continue the existing relationship” with Genentech

12/02/2009

A filing with the SEC says that Roche is not prepared to continue in a relationship with Genentech in which it owns a majority of the biotech’s equity but has limited involvement in its governance.

Genentech wanted $112 per share from Roche; SEC filing

11/02/2009

The strained relationship between Genentech and Roche has been revealed in a SEC filing, which details their differing valuations and accusations of misleading financial models.

Genentech “disappointed” at Roche’s hostile action

02/02/2009

Roche has stepped up its pursuit of Genentech, launching a hostile bid of $42bn after growing frustrated with the lack of progress over the past six months.

Genentech rejects Roche but leaves door ajar

14/08/2008

Genentech’s special advisory committee has rejected Roche’s $44bn offer for the biotech believing that it “substantially undervalues” the company.

Roche faces obstacles in acquiring Genentech

28/07/2008

Roche’s proposed $44bn acquisition of Genentech is facing some opposition with Wall Street saying the offer undervalues the company, disquiet among the biotech’s employees and shareholders suing th...

Roche shares dip on $43.7bn offer for Genentech

21/07/2008

Roche offered this morning to take complete control of US biotechnology giant Genentech for the princely sum of $43.7bn in a move that it says would “enhance innovation” and cut costs for both comp...

Full ScreenEmbed Widget

TimelineFlipbookListMap

Show/Hide Sources

Update Sources Now

Roche - Genentech takeover timeline

Description

Some Highlights From Recent Events

Comments

Followers

Today's Hot Topics

Featured Topics